Data were analyzed as a randomized complete block design using individual contrast statements to compare between treatments when the overall treatment factor was significant (P < 0.05).
To achieve this, a design of experiments with a treatment factor (the amount of fumed silica) at three different levels (0, 10 and 20 wt.%) is performed.
The trial is designed to have >85% power to detect a 25% relative reduction in the primary end point for each treatment factor.
A total of 24 plots of 112 m2 each were cultivated with Xaraes palisade grass was evaluated and carried with repeated measures (GCs) and one treatment factor (N rate) in completely randomized block design, with four replications.
Dry matter intake by sheep was not affected by either treatment factor (P>0.05), but DM digestibility and digestible DM intake were greater (P<0.05) from U compared with T. The in situ immediately soluble DM portion was greater from (P<0.05) L compared with H, but the reverse was true for the potentially degradable DM fraction.
The "treatment" factor (p = 0.1459) and the interaction factor (p = 0.3676) were not significant.
The treatment factor, soap, has been selected to have three levels: regular, deodorant, and moisturizing brands, from the same manufactory.
Similarly, the combination of sumatriptan and naproxen [24] resulted in more patients being sustained pain-free (24%) than after sumatriptan (16%) indicating a treatment factor for recurrence.
The fixed terms of the model contained 'phosphorous acid treatment' (factor with 3 levels: 0, 3 and 12 kg ha-1) and 'Phytophthora pathogen' (factor with 3 levels: control, P. pluvialis and P. kernoviae) and their interaction.
To verify this possibility, we performed a two-way ANOVA, with fluoxetine as the "pre-treatment" factor, and RS 67333 as the "treatment" factor.
The Treatment factor was significant for the duration head-dipping, F = 3.27, p = 0.010.
